This company listing is no longer active
0V43 Stock Overview
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
LexaGene Holdings Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.16 |
52 Week High | CA$0.25 |
52 Week Low | CA$0.16 |
Beta | 2.25 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -86.67% |
Change since IPO | -84.00% |
Recent News & Updates
Recent updates
Shareholder Returns
0V43 | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | 2.0% | 2.7% |
1Y | n/a | -8.5% | 0.3% |
Return vs Industry: Insufficient data to determine how 0V43 performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0V43 performed against the UK Market.
Price Volatility
0V43 volatility | |
---|---|
0V43 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0V43 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0V43's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 33 | Jack Regan | www.lexagene.com |
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.
LexaGene Holdings Inc. Fundamentals Summary
0V43 fundamental statistics | |
---|---|
Market cap | CA$14.78m |
Earnings (TTM) | -CA$11.50m |
Revenue (TTM) | CA$140.41k |
105.2x
P/S Ratio-1.3x
P/E RatioIs 0V43 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0V43 income statement (TTM) | |
---|---|
Revenue | US$104.27k |
Cost of Revenue | US$757.46k |
Gross Profit | -US$653.19k |
Other Expenses | US$7.89m |
Earnings | -US$8.54m |
Last Reported Earnings
Nov 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.061 |
Gross Margin | -626.46% |
Net Profit Margin | -8,189.91% |
Debt/Equity Ratio | 66.4% |
How did 0V43 perform over the long term?
See historical performance and comparison